142 related articles for article (PubMed ID: 30402138)
1. Maximin Efficiencies under Treatment-Dependent Costs and Outcome Variances for Parallel, AA/BB, and AB/BA Designs.
Candel MJJM
Comput Math Methods Med; 2018; 2018():8025827. PubMed ID: 30402138
[TBL] [Abstract][Full Text] [Related]
2. Parallel, AA/BB, AB/BA and Balaam's design: efficient and maximin choices when testing the treatment effect in a mixed effects linear regression.
Candel MJ
Pharm Stat; 2012; 11(2):97-106. PubMed ID: 22337606
[TBL] [Abstract][Full Text] [Related]
3. Best (but oft forgotten) practices: Efficient sample sizes for commonly used trial designs.
Candel MJJM; van Breukelen GJP
Am J Clin Nutr; 2023 Jun; 117(6):1063-1085. PubMed ID: 37270287
[TBL] [Abstract][Full Text] [Related]
4. Maximin design of cluster randomized trials with heterogeneous costs and variances.
van Breukelen GJP; Candel MJJM
Biom J; 2021 Oct; 63(7):1444-1463. PubMed ID: 34247406
[TBL] [Abstract][Full Text] [Related]
5. Optimal and maximin sample sizes for multicentre cost-effectiveness trials.
Manju MA; Candel MJ; Berger MP
Stat Methods Med Res; 2015 Oct; 24(5):513-39. PubMed ID: 25656551
[TBL] [Abstract][Full Text] [Related]
6. Sample size calculation for treatment effects in randomized trials with fixed cluster sizes and heterogeneous intraclass correlations and variances.
Candel MJ; van Breukelen GJ
Stat Methods Med Res; 2015 Oct; 24(5):557-73. PubMed ID: 25519890
[TBL] [Abstract][Full Text] [Related]
7. Sample size calculation in cost-effectiveness cluster randomized trials: optimal and maximin approaches.
Manju MA; Candel MJ; Berger MP
Stat Med; 2014 Jul; 33(15):2538-53. PubMed ID: 25019136
[TBL] [Abstract][Full Text] [Related]
8. Efficient treatment allocation in 2 × 2 multicenter trials when costs and variances are heterogeneous.
Lemme F; van Breukelen GJP; Candel MJJM
Stat Med; 2018 Jan; 37(1):12-27. PubMed ID: 28948651
[TBL] [Abstract][Full Text] [Related]
9. Efficient design of cluster randomized trials with treatment-dependent costs and treatment-dependent unknown variances.
van Breukelen GJP; Candel MJJM
Stat Med; 2018 Sep; 37(21):3027-3046. PubMed ID: 29888393
[TBL] [Abstract][Full Text] [Related]
10. Efficient design of cluster randomized and multicentre trials with unknown intraclass correlation.
van Breukelen GJ; Candel MJ
Stat Methods Med Res; 2015 Oct; 24(5):540-56. PubMed ID: 21937473
[TBL] [Abstract][Full Text] [Related]
11. Efficient treatment allocation in 2 × 2 cluster randomized trials, when costs and variances are heterogeneous.
Lemme F; van Breukelen GJ; Berger MP
Stat Med; 2016 Oct; 35(24):4320-4334. PubMed ID: 27271007
[TBL] [Abstract][Full Text] [Related]
12. An overview of optimal designs under a given budget in cluster randomized trials with a binary outcome.
Liu J; Liu L; James AS; Colditz GA
Stat Methods Med Res; 2023 Jul; 32(7):1420-1441. PubMed ID: 37284817
[TBL] [Abstract][Full Text] [Related]
13. Cost-efficient designs for three-arm trials with treatment delivered by health professionals: Sample sizes for a combination of nested and crossed designs.
Moerbeek M
Clin Trials; 2018 Apr; 15(2):169-177. PubMed ID: 29316807
[TBL] [Abstract][Full Text] [Related]
14. Implementing unequal randomization in clinical trials with heterogeneous treatment costs.
Sverdlov O; Ryeznik Y
Stat Med; 2019 Jul; 38(16):2905-2927. PubMed ID: 31049999
[TBL] [Abstract][Full Text] [Related]
15. Incorporating cost in power analysis for three-level cluster-randomized designs.
Konstantopoulos S
Eval Rev; 2009 Aug; 33(4):335-57. PubMed ID: 19509118
[TBL] [Abstract][Full Text] [Related]
16. Randomized, placebo-controlled, parallel group versus crossover study designs for the study of dementia in Parkinson's disease.
Putt ME; Ravina B
Control Clin Trials; 2002 Apr; 23(2):111-26. PubMed ID: 11943439
[TBL] [Abstract][Full Text] [Related]
17. Sample size determination for testing equality in Poisson frequency data under an AB/BA crossover trial.
Lui KJ
Pharm Stat; 2013; 12(2):74-81. PubMed ID: 23364859
[TBL] [Abstract][Full Text] [Related]
18. Repairing the efficiency loss due to varying cluster sizes in two-level two-armed randomized trials with heterogeneous clustering.
Candel MJ; Van Breukelen GJ
Stat Med; 2016 May; 35(12):2000-15. PubMed ID: 26756696
[TBL] [Abstract][Full Text] [Related]
19. A stepped wedge design for testing an effect of intranasal insulin on cognitive development of children with Phelan-McDermid syndrome: A comparison of different designs.
Van den Heuvel ER; Zwanenburg RJ; Van Ravenswaaij-Arts CM
Stat Methods Med Res; 2017 Apr; 26(2):766-775. PubMed ID: 25411323
[TBL] [Abstract][Full Text] [Related]
20. Design and analysis issues for crossover designs in phase I clinical studies.
Boon PC; Roes KC
J Biopharm Stat; 1999 Mar; 9(1):109-28. PubMed ID: 10091913
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
